Search
Humacyte Inc
HUMAAdd to Watchlist
0.561USD
-0.005-0.88%
Market hours 09/24, 15:10（ET）
151.27MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-0.88%
5 Days
-1.58%
1 Month
-12.62%
6 Months
-34.00%
Year to Date
-41.62%
1 Year
-67.00%
Key Figures
0.559Open
0.588High
118.46KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
0.566Prev. Close
0.543Low
65.65KTurnover
LossP/E Static
4.84P/B
0.00%Div Yield TTM
-71.47%ROA
2.55052wk High
0.03Volume Ratio
-148.70MNet Profit
269.64MShares
-0.6449EPS TTM
2.14Beta
-409.47%ROE
0.52652wk Low
7.95%Amplitude
-262.82%Gross Margin
151.27MMarket Cap
-1.29Reward/Risk
7.18%Risk Rate
Humacyte Inc's Score
0.16vs previous score
Forecast8.00
Financial Health6.08
Technical4.50
Valuation Dimensions7.60
Institutional Confidence3.00
Risk Assessment2.69
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Humacyte Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Strong sell
Moving Average
Strong sell
Humacyte Inc Latest Earnings Call Transcripts
Humacyte (HUMA) Q2 2026 Earnings Call: Dialysis sBLA Targeted for November
Humacyte’s Q2 2026 earnings call covered $0.4 million in sales, positive V012 dialysis data and a November target for its ATEV sBLA filing.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.16/-0.10
Revenue / Forecast
406.00K/1.12M
Humacyte Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolHUMA
Number of employees218
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Fresenius SE & Co KGaA | 8.25% |
| BlackRock Institutional Trust Company, N.A. | 4.70% |
| Vanguard Capital Management, LLC | 3.22% |
| Antipodes Partners Limited | 2.58% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 16.40% |
| Corporation | 8.25% |
| Investment Advisor/Hedge Fund | 4.86% |
| Hedge Fund | 4.17% |
Related Instruments
+3.25%
+0.98%
+0.13%
+0.51%
+0.43%
+1.13%
+0.23%
-0.69%
+0.43%
+0.89%
+1.20%
-0.64%
-1.00%
0.00%
-1.67%
-0.87%
+5.90%
+1.25%
-1.09%
+0.83%Popular Instruments
51334.400
-155.600 (-0.30%)
30452.000
-25.900 (-0.09%)
7704.700
-2.300 (-0.03%)
14264.000
-158.000 (-1.10%)
65768.000
-361.000 (-0.55%)
6303.200
+13.200 (+0.21%)
94.863
+2.373 (+2.57%)
337.720
+0.700 (+0.21%)
223.800
-1.710 (-0.76%)
4269.400
-16.840 (-0.39%)
FAQs
What is the current price of Humacyte Inc (HUMA)?
The current price of Humacyte Inc (HUMA) is 0.57.
What is the symbol of Humacyte Inc?
The ticker symbol of Humacyte Inc is HUMA.
What is the 52-week high of Humacyte Inc?
The 52-week high of Humacyte Inc is 2.55.
What is the 52-week low of Humacyte Inc?
The 52-week low of Humacyte Inc is 0.53.
What is the market capitalization of Humacyte Inc?
The market capitalization of Humacyte Inc is 152.62M.
Is Humacyte Inc (HUMA) currently rated as Buy, Hold, or Sell?
According to analysts, Humacyte Inc (HUMA) has an overall rating of Buy, with a price target of 1.85.
What is the Earnings Per Share (EPS TTM) of Humacyte Inc (HUMA)?
The Earnings Per Share (EPS TTM) of Humacyte Inc (HUMA) is -0.64.